NCT00198263View on ClinicalTrials.gov

Study Using the Medpulser Electroporation System With Bleomycin to Treat Head and Neck Cancer

PHASE4CompletedINTERVENTIONAL
Enrollment

95

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
Head and Neck Cancer
Interventions
COMBINATION_PRODUCT

Medpulser Electroporation with Bleomycin

The MedPulser device will be used in conjunction with injection of Bleomycin Sulfate at a concentration of 1 U/ml per cm3 of tumor treatment area.

Trial Locations (1)

92121

Inovio Biomedical Corporation, San Diego

Sponsors
All Listed Sponsors
lead

Inovio Pharmaceuticals

INDUSTRY

NCT00198263 - Study Using the Medpulser Electroporation System With Bleomycin to Treat Head and Neck Cancer | Biotech Hunter | Biotech Hunter